Yescarta®
Company
Kite Pharma
Use
Treatment of relapsed or refractory large B-cell lymphoma.
Features
CAR T-cell immunotherapy
NIH Contribution
Research in CAR T-cell technology: Dual-target CAR for enhanced cancer therapy
HHS Institute/Agency
NCI
Inventor(s)
Kochenderfer, J. et al.
Year
2017
